• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病理学家在诊断和分级胆道疾病中的作用。

The role of the pathologist in diagnosing and grading biliary diseases.

机构信息

Department of human pathology, Kanazawa University Graduate School of Medicine, Kanazawa 920-8640, Japan.

出版信息

Clin Res Hepatol Gastroenterol. 2011 May;35(5):347-52. doi: 10.1016/j.clinre.2011.01.018. Epub 2011 Apr 6.

DOI:10.1016/j.clinre.2011.01.018
PMID:21474418
Abstract

Pathological features of primary biliary cirrhosis (PBC) are reviewed. Immune-mediated, non-suppurative cholangitis is the initial lesion and is followed by the gradual and extensive destruction of bile ducts and development of chronic cholestasis. Simultaneously, necro-inflammatory activities of the hepatic parenchyma and limiting plates of milder form develop not infrequently. Eventually, liver fibrosis and cirrhosis develop. A new system applicable to needle liver biopsies in which staging is evaluated using a combination of three factors (fibrosis, cholestasis, and bile duct loss) and necro-inflammatory activities of the bile duct and hepatic parenchyma are graded, is proposed. The clinical and therapeutic evaluation of PBC using this system is warranted.

摘要

原发性胆汁性肝硬化(PBC)的病理特征如下。免疫介导的非化脓性胆管炎是初始病变,随后逐渐广泛地破坏胆管并发展为慢性胆汁淤积。同时,肝脏实质和较轻微形式的限制板的坏死性炎症活动也经常发生。最终,肝纤维化和肝硬化发展。提出了一种新的适用于针吸肝活检的系统,该系统使用组合三种因素(纤维化、胆汁淤积和胆管丢失)以及胆管和肝实质的坏死性炎症活动来评估分期,并对其进行分级。使用该系统对 PBC 进行临床和治疗评估是合理的。

相似文献

1
The role of the pathologist in diagnosing and grading biliary diseases.病理学家在诊断和分级胆道疾病中的作用。
Clin Res Hepatol Gastroenterol. 2011 May;35(5):347-52. doi: 10.1016/j.clinre.2011.01.018. Epub 2011 Apr 6.
2
Proposal of a new staging and grading system of the liver for primary biliary cirrhosis.原发性胆汁性肝硬化肝脏新分期和分级系统的提议。
Histopathology. 2006 Nov;49(5):466-78. doi: 10.1111/j.1365-2559.2006.02537.x.
3
Application and validation of a new histologic staging and grading system for primary biliary cirrhosis.原发性胆汁性肝硬化新组织学分期和分级系统的应用和验证。
J Clin Gastroenterol. 2013 Feb;47(2):174-81. doi: 10.1097/MCG.0b013e31827234e4.
4
Evaluation of a new histologic staging and grading system for primary biliary cirrhosis in comparison with classical systems.原发性胆汁性肝硬化新组织学分期和分级系统与经典系统的比较评估。
Hum Pathol. 2013 Jun;44(6):1107-17. doi: 10.1016/j.humpath.2012.09.017. Epub 2013 Jan 11.
5
Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: Interobserver agreement.原发性胆汁性肝硬化新的组织学分期和分级系统在肝活检标本中的应用:观察者间一致性。
Pathol Int. 2010 Mar;60(3):167-74. doi: 10.1111/j.1440-1827.2009.02500.x.
6
Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis.原发性胆汁性肝硬化中增强的细胞凋亡与胆管丢失有关。
Hepatology. 1997 Dec;26(6):1399-405. doi: 10.1002/hep.510260604.
7
Frequent expression of MUC1 apomucin on biliary epithelial cells of damaged small bile ducts in primary biliary cirrhosis and chronic viral hepatitis: an immunohistochemical study.原发性胆汁性肝硬化和慢性病毒性肝炎中受损小胆管的胆管上皮细胞上MUC1脱糖基粘蛋白的频繁表达:一项免疫组织化学研究
Hepatology. 1996 Jun;23(6):1313-7. doi: 10.1053/jhep.1996.v23.pm0008675144.
8
The pathology of primary biliary cirrhosis and autoimmune cholangitis.原发性胆汁性肝硬化和自身免疫性胆管炎的病理学
Baillieres Best Pract Res Clin Gastroenterol. 2000 Aug;14(4):601-13. doi: 10.1053/bega.2000.0106.
9
[Morphogenesis of primary biliary liver cirrhosis].
Arkh Patol. 1988;50(2):19-24.
10
Frequent cellular senescence in small bile ducts in primary biliary cirrhosis: a possible role in bile duct loss.原发性胆汁性肝硬化中小胆管频繁出现细胞衰老:在胆管丢失中的可能作用。
J Pathol. 2005 Mar;205(4):451-9. doi: 10.1002/path.1729.

引用本文的文献

1
Primary biliary cirrhosis: From bench to bedside.原发性胆汁性肝硬化:从实验室到临床
World J Gastrointest Pharmacol Ther. 2015 Aug 6;6(3):32-58. doi: 10.4292/wjgpt.v6.i3.32.